Meet two of OPEN Health’s practices – Peloton Advantage and Pharmerit at MAPS 2020
March 3, 2020 |
Turning scientific knowledge and data into evidence
March 3, 2020 – London, UK, Parsippany and Bethesda, USA – Meet two of OPEN Health’s practices—Peloton Advantage and Pharmerit International—at booth #4 at MAPS Global 2020, the World’s Largest Assembly of Medical Affairs Professionals, to be held in Miami, Florida from March 8 – 11, 2020.
Peloton Advantage along with OPEN Health Medical Communications provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training. By joining OPEN Health in late 2019, Pharmerit deepens OPEN Health’s strategic and scientific capabilities in health economics and outcomes research (HEOR) and market access and expands Pharmerit’s ability to communicate with the broader scientific community. For more information on the two practices, please visit our website.
OPEN Health practices are supported by creative and digital teams to translate scientific concepts and communications into compelling visuals and deliver innovation with measurable results, all while ensuring data security and compliance. Together, the OPEN Health family is a full-service, trusted, innovative partner for Medical Affairs.
Contact:
OPEN Health: Sandy Royden
sandyroyden@openhealthgroup.com
+44 1628 481112
Peloton Advantage: Carolyn Clark
cclark@pelotonadvantage.com
+1 973 582 5701
Pharmerit International: Candice Subero
+1 240 483 4323
About OPEN Health Communications, LLP:
OPEN Health is a global multidisciplinary health communications and market access group, operating within three core business areas: Medical Communications; Patient and Brand Communications; and HEOR / Access and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases, and specialist medicines.
For further information on OPEN Health, please visit www.openhealthgroup.com.
About Pharmerit International, LP:
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in health economics and outcomes research (HEOR) and market access worldwide. Pharmerit delivers quality research across four multidisciplinary Centers of Excellence: Modeling & Meta-Analysis, Patient-Centred Outcomes, Real-World Evidence, and Strategic Market Access.Pharmerit has offices in Berlin, Bethesda, Boston, Mumbai, Oxford, New York, Rotterdam, York, and Shanghai.
For further information on Pharmerit International, please visit www.pharmerit.com.
About Peloton Advantage, LLC:
Peloton Advantage, LLC is a privately-owned medical communications company specializing in strategic publication planning and associated content development for medical education programs. Peloton’s teams support US and global accounts for large and small pharmaceutical, biotechnology, and medical device companies, contributing to the success of more than 90 products spanning all major therapeutic areas.
For further information on Peloton Advantage, please visit www.pelotonadvantage.com.
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer
Unlock possibilities: A Medical Affairs strategy fit for the future
Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.
OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
OPEN Health unites patient engagement experts to transform the patient experience
OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement,...
The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease
The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice
Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice
Embracing the Patient Voice Within Publications
This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...
Navigating the nocebo effect through patient engagement is the key to setting patients up for success
If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.